The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients

N Bayrakci1, N Ozkayar1, F Akyel2

  • 1Department of Nephrology, Ankara Numune Education and Research Hospital, Ankara, Turkey.

Hippokratia
|July 16, 2016
PubMed

Insights

Non-dipper hypertension is linked to higher cardiovascular disease risk and increased inflammation. This study found a significantly higher platelet-to-lymphocyte ratio (PLR) in non-dipper hypertensive patients, suggesting a role for inflammation in this condition.

Area of Science:

  • Cardiology
  • Hematology
  • Hypertension Research

Background:

  • Non-dipper hypertension is associated with increased cardiovascular disease (CVD) risk compared to dipper hypertension.
  • Inflammation is a key factor in the development and progression of CVD.

Purpose of the Study:

  • To investigate the relationship between the platelet-to-lymphocyte ratio (PLR) and hypertension status (dipper vs. non-dipper).

Main Methods:

  • A prospective study involving 199 primary hypertension patients.
  • Patients were classified into dipper and non-dipper groups based on ambulatory blood pressure monitoring.
  • Platelet-to-lymphocyte ratio (PLR) was calculated from complete blood count data.

Main Results:

  • The non-dipper group (103 patients) had significantly higher mean systolic blood pressure and median PLR compared to the dipper group (96 patients).
  • The non-dipper group exhibited significantly lower white blood cell and lymphocyte counts.
  • Median PLR was significantly elevated in non-dipper hypertensive patients (132.15) versus dipper patients (117.0).

Conclusions:

  • Median PLR is significantly higher in non-dipper hypertensive patients compared to dipper hypertensive patients.
  • This finding supports the involvement of increased inflammatory response in non-dipper hypertension.
Abstract

Related Concept Videos